echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Professor Tong Nanwei: Where is the "new" in the Expert Consensus on Personalized Hypoglycemic Therapy for T2DM Initiation in Newly Diagnosed Adults Without Clinical CVD or CKD?

    Professor Tong Nanwei: Where is the "new" in the Expert Consensus on Personalized Hypoglycemic Therapy for T2DM Initiation in Newly Diagnosed Adults Without Clinical CVD or CKD?

    • Last Update: 2022-10-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    "The following content is for medical pharmacy professionals only, if you are not a professional of the foregoing, please leave this page immediately"



    -End-


    "This article is only for providing scientific information to medical and health professionals, and does not represent the position of the platform" Submission/reprint/business cooperation, please contact: pengsanmei@yxj.
    org.
    cn
    ↓↓↓ Click "Read Original"

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.